Wellington Management Group’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Sell
111,752
-22,794
-17% -$288K ﹤0.01% 1637
2025
Q4
$2.23M Sell
134,546
-11,913
-8% -$170K ﹤0.01% 1576
2025
Q3
$1.72M Buy
+146,459
New +$1.51M ﹤0.01% 1671
2025
Q2
Sell
-200,690
Closed -$1.26M 2026
2025
Q1
$1.26M Buy
200,690
+64,695
+48% +$393K ﹤0.01% 1654
2024
Q4
$1.1M Sell
135,995
-37,388
-22% -$463K ﹤0.01% 1699
2024
Q3
$3.13M Sell
173,383
-53,258
-23% -$744K ﹤0.01% 1439
2024
Q2
$2.33M Buy
226,641
+3,251
+1% +$33.5K ﹤0.01% 1485
2024
Q1
$2.37M Buy
223,390
+68,999
+45% +$586K ﹤0.01% 1487
2023
Q4
$1.41M Buy
154,391
+54,581
+55% +$470K ﹤0.01% 1558
2023
Q3
$1.04M Buy
99,810
+1,797
+2% +$24.6K ﹤0.01% 1604
2023
Q2
$1.4M Buy
+98,013
New +$1.13M ﹤0.01% 1549

Other funds holding PHAT